Robert Dickey IV
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert Dickey IV
Robert Dickey IV is recorded as CFO at Enveric Biosciences, Inc. (ENVB). Enveric Biosciences, Inc. reported in an 8-K filed February 28, 2023 that Robert Dickey IV resigned as chief financial officer, effective March 13, 2023. Enveric Biosciences, Inc. reported in an 8-K filed September 13, 2022 that Robert Dickey IV was appointed Chief Financial Officer ("CFO"), effective September 9, 2022.
“Effective as of the Effective Date, Robert Dickey IV will resign from his position as the Company's chief financial officer.”
“On September 9, 2022, Robert Dickey IV was appointed as the Chief Financial Officer ("CFO") of the Company, to serve on an interim basis, effective September 9, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-09–present
-
2022-09-09–2023-03-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Enveric Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- David Johnson CEO, Board Member
- Dr. Joseph Tucker CEO, Board Member
- Joseph Tucker CEO, Board Member
- Dave Johnson Chairman
- Michael D. Webb Chairman, Board Member
- Michael Webb Chairman, Board Member
- Carter J. Ward CFO
- John Van Buiten CFO
- Kevin Coveney CFO
- Kevin M. Coveney CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.